4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-22-003358
EVP, Drug Development gave up 2,012 shares (to pay taxes)
- EVP, Drug Development acquired 5,814 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MANHARD KIMBERLY EVP, Drug Development | 2022-01-13 | Option exercise | +1,250 | 4,518 | D | ||
| MANHARD KIMBERLY EVP, Drug Development | 2022-01-13 | Option exercise | +4,564 | 9,082 | D | ||
| MANHARD KIMBERLY EVP, Drug Development | 2022-01-13 | Shares withheld for taxes | −2,012 | $8.30 | $16,700 | 7,070 | D |
| Derivatives | |||||||
| MANHARD KIMBERLY EVP, Drug Development | 2022-01-13 | Option exercise · Restricted Stock Units | −1,250 | 13,750 | D | ||
| MANHARD KIMBERLY EVP, Drug Development | 2022-01-13 | Option exercise · Restricted Stock Units | −4,564 | 50,756 | D | ||
Loading xslF345X03/doc4.xml…